Retraction
GBP1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Wnt/β-catenin signaling pathway
Paper Information
Record ID:
28053
Author(s):
Publication Date:
May 15, 2020
Retraction Date:
July 15, 2020
(5.3 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Verduci Editore
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.26355/eurrev_202007_21872Additional Notes:
See also: https://pubpeer.com/publications/44EDF640F47262B6588AC9892D3F0E; See also: https://scienceintegritydigest.com/2020/07/05/the-stock-photo-paper-mill/; See also: https://www.europeanreview.org/wp/wp-content/uploads/7908-7908.pdf
Citations (1)
1
Total Citations1
Post-Retraction(100.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
1
After 2+ years
900
Days since retraction (latest)
The function of guanylate binding protein 3 (GBP3) in human cancers by pan-cancer bioinformatics
Tongmeng Jiang, Jin Pan, Huang Guo-xiu et al. (4 authors)
Mathematical Biosciences & Engineering
Open Access
Published: Jan 2023
900 days after retraction
Quick Stats
Total Citations:
1
Years Since Retraction:
5.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025